Tribulus terrestris (Tribulus)

Tribulus terrestris is a flowering plant whose primary bioactive compounds, steroidal saponins (particularly protodioscin), are thought to influence androgen receptor activity and nitric oxide pathways. It is studied clinically for improving sexual function in both men and women, though its effects on testosterone levels in healthy individuals remain unsupported by robust evidence.

Origin & History

Tribulus terrestris is an annual plant in the Zygophyllaceae family, native to warm temperate and tropical regions including Europe, Asia, Africa, and Australia, commonly known as puncture vine or Gokshura. The supplement is sourced from the dried aerial parts (leaves, stems, flowers) of the plant, with extracts typically prepared using dry extraction methods at ratios like 35-45:1, yielding a dry extract standardized to furostanol saponins (minimum 45%).

Historical & Cultural Context

Tribulus terrestris has long been believed to possess aphrodisiac properties in traditional medicine, used for enhancing sexual function and libido. Historical use spans systems like Ayurveda (where it's known as Gokshura) and traditional Chinese medicine, though specific durations and systems are not quantified in sources.

Health Benefits

• Improves female sexual function in women with hypoactive sexual desire disorder (HSDD) - moderate evidence from RCT showing significant improvements in desire, arousal, lubrication, and satisfaction (PMID: 24817920)
• Enhances erectile function in men with mild-moderate ED - moderate evidence from large RCT (n=180) showing significant IIEF score improvements (PMID: 28364864)
• Supports sexual function in postmenopausal women - moderate evidence from RCT showing FSFI improvements in most domains (PMID: 27760089)
• May improve overall sexual satisfaction - consistent finding across multiple RCTs in both men and women
• Testosterone effects remain unproven - systematic reviews show no consistent testosterone increases with Tribulus alone in humans (PMID: 24559105, 40219032)

How It Works

The steroidal saponin protodioscin is hypothesized to be converted to DHEA, weakly upregulating androgen receptor sensitivity rather than directly elevating serum testosterone. Protodioscin also appears to stimulate endothelial nitric oxide synthase (eNOS) activity, increasing nitric oxide bioavailability in vascular smooth muscle, which supports penile and clitoral blood flow. Additionally, some animal data suggest modulation of the hypothalamic-pituitary-gonadal axis via luteinizing hormone (LH) release, though this has not been consistently replicated in human trials.

Scientific Research

Clinical evidence includes three key RCTs: one in 67 women with HSDD using 7.5 mg/day for 4 weeks (PMID: 24817920), another in 180 men with ED using 1500 mg/day standardized extract for 12 weeks (PMID: 28364864), and a third in 45 postmenopausal women using 750 mg/day for 120 days (PMID: 27760089). Two systematic reviews found low evidence for testosterone effects and concluded inconsistent results for hormonal parameters (PMID: 24559105, 40219032).

Clinical Summary

A randomized controlled trial (PMID: 24817920) in women with hypoactive sexual desire disorder (HSDD) demonstrated statistically significant improvements in desire, arousal, lubrication, and satisfaction using 7.5 mg/day of a standardized Tribulus extract over 4 weeks. In men with mild-to-moderate erectile dysfunction, RCT data show meaningful improvements in IIEF scores with doses of 250–1500 mg/day of standardized extract, though sample sizes have generally been small (n=30–90). Notably, multiple well-controlled studies in healthy male athletes found no significant increase in serum testosterone, LH, or muscle mass, contrasting with widespread marketing claims. Overall, evidence quality is moderate for sexual dysfunction indications and weak-to-absent for testosterone enhancement or athletic performance.

Nutritional Profile

Tribulus terrestris is a medicinal herb, not a significant source of macronutrients or conventional micronutrients. Key bioactive compounds include: Steroidal saponins (primary active constituents, 40-60% in standardized extracts) dominated by protodioscin (typically 6-45% in aerial parts, higher in roots from Eastern European sources vs. lower in Asian varieties), protodiosci, dioscin, and gracillin. Furostanol saponins (including terrestrosin A-E) concentrated in fruits and roots. Flavonoids: kaempferol, quercetin, and isorhamnetin at approximately 0.1-0.5% dry weight. Alkaloids: harmane, norharmane, and tribulusterine at trace levels (<0.1%). Phytosterols including beta-sitosterol (~0.05-0.1%). Tannins approximately 3-5% dry weight. Phenolic acids including ferulic acid and caffeic acid at trace levels. Polysaccharides contributing to fiber content (~8-12% crude fiber in whole plant). Mineral content includes calcium (~1,200 mg/100g dry weight), potassium (~800 mg/100g), magnesium (~180 mg/100g), phosphorus (~150 mg/100g), and iron (~15 mg/100g). Protein content is approximately 15-18% in dried aerial parts. Bioavailability note: Protodioscin bioavailability is moderate and highly dependent on gut microbiota for hydrolysis to dehydroepiandrosterone (DHEA)-like metabolites; standardized extract concentrations (40% saponins by spectrophotometry) are used in most clinical research. Geographic origin significantly affects saponin profiles, with Bulgarian/Eastern European sourcing yielding higher protodioscin concentrations than Indian or Chinese sources.

Preparation & Dosage

Clinically studied doses include 7.5 mg/day extract for female HSDD (4 weeks), 1500 mg/day (6×250 mg tablets) of standardized extract (≥45% furostanol saponins) for male ED (12 weeks), and 750 mg/day for postmenopausal sexual function (120 days). Only standardized extracts (35-45:1) were studied; no data on powder forms. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Maca, L-arginine, Panax ginseng, Ashwagandha, Zinc

Safety & Interactions

Tribulus terrestris is generally well tolerated at studied doses (250–1500 mg/day), with mild gastrointestinal upset being the most commonly reported side effect in clinical trials. Animal studies have linked very high-dose or prolonged exposure to nephrotoxicity and potential hepatotoxicity, though these effects have not been clearly established in human clinical doses. It may potentiate antihypertensive medications and anticoagulants such as warfarin due to its vasodilatory and potential platelet-modulating properties, warranting caution in those on such therapies. Use during pregnancy and lactation is not recommended due to insufficient safety data and historical use as an abortifacient in traditional medicine.